Your browser doesn't support javascript.
loading
[Proteomic study of Jingfang Mixture on urticaria based on label-free quantitative proteomics technology].
Cheng, Yu; Pan, Li-Hong; Li, Shi-Rong; Zhang, Li; Niu, De-Jun; Sun, Cheng-Hong; Guan, Yong-Xia.
Afiliação
  • Cheng Y; Xuzhou Medical University Xuzhou 221004, China.
  • Pan LH; State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine Linyi 276006, China Center for New Drug Pharmacology, Lunan Pharmaceutical Group Co., Ltd. Linyi 273400, China.
  • Li SR; State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine Linyi 276006, China Center for New Drug Pharmacology, Lunan Pharmaceutical Group Co., Ltd. Linyi 273400, China.
  • Zhang L; State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine Linyi 276006, China Center for New Drug Pharmacology, Lunan Pharmaceutical Group Co., Ltd. Linyi 273400, China.
  • Niu DJ; State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine Linyi 276006, China Center for New Drug Pharmacology, Lunan Pharmaceutical Group Co., Ltd. Linyi 273400, China.
  • Sun CH; State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine Linyi 276006, China Center for New Drug Pharmacology, Lunan Pharmaceutical Group Co., Ltd. Linyi 273400, China.
  • Guan YX; State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine Linyi 276006, China.
Zhongguo Zhong Yao Za Zhi ; 47(20): 5494-5501, 2022 Oct.
Article em Zh | MEDLINE | ID: mdl-36471965
This study aims to explore the effect of Jingfang Mixture on the protein expression of urticaria in mice and explain the mechanism of Jingfang Mixture in the treatment of urticaria. Twenty-seven male Kunming mice were randomly divided into a normal group, a model group and a Jingfang Mixture group according to body weight. Except for the normal group, mice in the model group and the Jingfang Mixture group were injected with the mixture of ovalbumin and Al(OH)_3 gel for the first immunization, and the second immunization was performed on the 10 th day to induce the urticaria model. Mice in the Jingfang Mixture group started to be administered on the 6 th day after the initial immunization, and was administered continuously for 21 days. The normal group and the model group were replaced with the same amount of purified water. Twenty-four hours after the last administration, an appropriate amount of skin was taken, and label-free quantitative proteomics technology was used to detect the differences in protein expression in skin tissue. The signaling pathways involved in the differential proteins was further analyzed. The results of proteomics indicated that seventy-six proteins were involved in the intervention of Jingfang Mixture on mice with urticaria, and the differential proteins were mainly enriched in biological process(BP), molecular function(MF), and cellular component(CC). Kyoto Encyclopedia of Genes and Genomes(KEGG) analysis showed that the signaling pathways regulated by Jingfang Mixture mainly involved carbon metabolism, metabolic pathways, glucagon signaling pathway, glycolysis/gluconeogenesis, pentose phosphate pathway, hypoxia inducible factor-1(HIF-1) signaling pathway, purine metabolism, adherens junction, calcium signaling pathway, leukocyte transendothelial migration, and inflammatory mediator regulation of transient receptor potential(TRP) channels, which were involved in skin tissue energy metabolism and immune regulation. The findings of this study showed that the protective effect of Jingfang Mixture on mice with urticaria was closely related to the regulation of immune disorders, and the regulatory effect on immune system may be achieved through the regulation of energy metabolism by Jingfang Mixture.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urticária / Proteômica Tipo de estudo: Prognostic_studies Limite: Animals Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Assunto da revista: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urticária / Proteômica Tipo de estudo: Prognostic_studies Limite: Animals Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Assunto da revista: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: China